RXi Pharmaceuticals Probability of Future Stock Price Finishing Under 2.12

RXi Pharmaceuticals' future price is the expected price of RXi Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of RXi Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
  
Please specify RXi Pharmaceuticals' target price for which you would like RXi Pharmaceuticals odds to be computed.

RXi Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of RXi Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for RXi Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
RXi Pharmaceuticals is not yet fully synchronised with the market data
RXi Pharmaceuticals has some characteristics of a very speculative penny stock
RXi Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 153 K. Net Loss for the year was (7.63 M) with loss before overhead, payroll, taxes, and interest of (5.36 M).
RXi Pharmaceuticals currently holds about 3.24 M in cash with (7.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.

RXi Pharmaceuticals Technical Analysis

RXi Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. RXi Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of RXi Pharmaceuticals. In general, you should focus on analyzing RXi Stock price patterns and their correlations with different microeconomic environments and drivers.

RXi Pharmaceuticals Predictive Forecast Models

RXi Pharmaceuticals' time-series forecasting models is one of many RXi Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary RXi Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about RXi Pharmaceuticals

Checking the ongoing alerts about RXi Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for RXi Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
RXi Pharmaceuticals is not yet fully synchronised with the market data
RXi Pharmaceuticals has some characteristics of a very speculative penny stock
RXi Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 153 K. Net Loss for the year was (7.63 M) with loss before overhead, payroll, taxes, and interest of (5.36 M).
RXi Pharmaceuticals currently holds about 3.24 M in cash with (7.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in RXi Stock

If you are still planning to invest in RXi Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RXi Pharmaceuticals' history and understand the potential risks before investing.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
CEOs Directory
Screen CEOs from public companies around the world
Commodity Directory
Find actively traded commodities issued by global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules